Clinical Trials Browser

Phase 2 × Recruiting × Carcinoma, Ovarian Epithelial × Clear all

NCT06890338 2026-02-24

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Phase 2 Recruiting

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT07303894 2026-01-29

A Study of Isoquercetin in People With Ovarian Cancer

Phase 2 Recruiting

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT06690775 2025-12-23

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Phase 2 Recruiting

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT04644289 2025-10-03

WoO

Phase 2 Recruiting

Carcinoma, Ovarian Epithelial

NCT07171528 2025-09-12

KOV-02S

Phase 2 Recruiting

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT04519151 2023-06-08

Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer

Phase 2 Recruiting

GastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Genital Neoplasms, Female, Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Stomach Neoplasms, Urogenital Neoplasms

NCT04834544 2021-05-03

A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care

Phase 2 Recruiting

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT03025477 2021-02-11

CHIMOVIP

Phase 2 Recruiting

Carcinoma, Ovarian Epithelial